Trial intelligence / Profile preview

Hydrogel containing gentamicin for pressure ulcer healing

IRCT20181105041563N6Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Nov 2020
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, open-label trial of gentamicin in decubitus ulcer (3 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Healing of pressure ulcer. Started Nov 2020; status: completed.

02

Drugs

gentamicin
03

Conditions

decubitus ulcer

Beyond the preview

Go deeper on IRCT20181105041563N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181105041563N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call